ICHN Stock Overview
iShares IV Public Limited Company - iShares MSCI China A UCITS ETF is an exchange traded fund launched by BlackRock Asset Management Ireland Limited.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 0/6 |
Dividends | 0/6 |
iShares IV Public Limited Company - iShares MSCI China UCITS ETF Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | €5.07 |
52 Week High | €5.17 |
52 Week Low | €3.46 |
Beta | 0 |
11 Month Change | 25.09% |
3 Month Change | 20.10% |
1 Year Change | 27.77% |
33 Year Change | -14.55% |
5 Year Change | 2.08% |
Change since IPO | -3.31% |
Recent News & Updates
No updates
Recent updates
No updates
Shareholder Returns
ICHN | NL Capital Markets | NL Market | |
---|---|---|---|
7D | 12.3% | -1.4% | 1.6% |
1Y | 27.8% | 20.6% | 26.2% |
Return vs Industry: ICHN exceeded the Dutch Capital Markets industry which returned 20.6% over the past year.
Return vs Market: ICHN exceeded the Dutch Market which returned 26.2% over the past year.
Price Volatility
ICHN volatility | |
---|---|
ICHN Average Weekly Movement | 3.8% |
Capital Markets Industry Average Movement | 3.7% |
Market Average Movement | 4.3% |
10% most volatile stocks in NL Market | 7.4% |
10% least volatile stocks in NL Market | 2.3% |
Stable Share Price: ICHN has not had significant price volatility in the past 3 months.
Volatility Over Time: ICHN's weekly volatility (4%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2015 | n/a | n/a | www.ishares.com/uk/individual/en/products/273192/CNYA |
iShares IV Public Limited Company - iShares MSCI China A UCITS ETF is an exchange traded fund launched by BlackRock Asset Management Ireland Limited. It is managed by BlackRock Advisors (UK) Limited. The fund invests in the public equity markets of China.
iShares IV Public Limited Company - iShares MSCI China UCITS ETF Fundamentals Summary
ICHN fundamental statistics | |
---|---|
Market cap | US$1.34b |
Earnings (TTM) | US$0 |
Revenue (TTM) | n/a |
n/a
P/E Ration/a
P/S RatioIs ICHN overvalued?
See Fair Value and valuation analysisEarnings & Revenue
ICHN income statement (TTM) | |
---|---|
Revenue | US$0 |
Cost of Revenue | US$0 |
Gross Profit | US$0 |
Other Expenses | US$0 |
Earnings | US$0 |
Last Reported Earnings
n/a
Next Earnings Date
n/a
Earnings per share (EPS) | 0 |
Gross Margin | 0.00% |
Net Profit Margin | 0.00% |
Debt/Equity Ratio | 0.0% |
How did ICHN perform over the long term?
See historical performance and comparison